Boryung Pharmaceutical Reports Operating Profit of 13.4 Billion KRW in Q1, Up 42% Year-on-Year
[Asia Economy Reporter Yoo Byung-don] Boryung Pharmaceutical announced on the 24th that its consolidated operating profit for the first quarter of this year reached 13.395 billion KRW, an increase of 42.13% compared to the same period last year.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- [Breaking] President Lee: "Serious Damage from Fake AI Images... Accelerating Improvement of Related Regulations"
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Manhole Cover Blasts Open in 12 Seconds... The Reason Behind the 'Gangnam Flood Disaster' [Report]"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
During the same period, sales increased by 13.03% to 134.212 billion KRW, while net profit for the period decreased by 6.12% to 8.334 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.